Janus Henderson Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-15,332
| Closed | -$4.85M | – | 2594 |
|
2023
Q4 | $4.85M | Buy |
15,332
+1,472
| +11% | +$466K | ﹤0.01% | 835 |
|
2023
Q3 | $2.34M | Buy |
13,860
+27
| +0.2% | +$4.57K | ﹤0.01% | 1097 |
|
2023
Q2 | $3M | Buy |
13,833
+1,008
| +8% | +$218K | ﹤0.01% | 1043 |
|
2023
Q1 | $2.33M | Buy |
12,825
+7,339
| +134% | +$1.33M | ﹤0.01% | 1178 |
|
2022
Q4 | $1.08M | Buy |
5,486
+618
| +13% | +$122K | ﹤0.01% | 1313 |
|
2022
Q3 | $1.09M | Buy |
4,868
+970
| +25% | +$218K | ﹤0.01% | 1596 |
|
2022
Q2 | $493K | Buy |
3,898
+32
| +0.8% | +$4.05K | ﹤0.01% | 1778 |
|
2022
Q1 | $490K | Buy |
3,866
+6
| +0.2% | +$760 | ﹤0.01% | 1937 |
|
2021
Q4 | $506K | Buy |
3,860
+1,944
| +101% | +$255K | ﹤0.01% | 1892 |
|
2021
Q3 | $235K | Buy |
+1,916
| New | +$235K | ﹤0.01% | 2001 |
|